19-13298658-T-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001127222.2(CACNA1A):​c.2975A>T​(p.Glu992Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.143 in 1,502,488 control chromosomes in the GnomAD database, including 15,900 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E992Q) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.13 ( 1408 hom., cov: 32)
Exomes 𝑓: 0.14 ( 14492 hom. )

Consequence

CACNA1A
NM_001127222.2 missense

Scores

1
1
15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:13O:1

Conservation

PhyloP100: 2.84

Publications

22 publications found
Variant links:
Genes affected
CACNA1A (HGNC:1388): (calcium voltage-gated channel subunit alpha1 A) Voltage-dependent calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, and gene expression. Calcium channels are multisubunit complexes composed of alpha-1, beta, alpha-2/delta, and gamma subunits. The channel activity is directed by the pore-forming alpha-1 subunit, whereas, the others act as auxiliary subunits regulating this activity. The distinctive properties of the calcium channel types are related primarily to the expression of a variety of alpha-1 isoforms, alpha-1A, B, C, D, E, and S. This gene encodes the alpha-1A subunit, which is predominantly expressed in neuronal tissue. Mutations in this gene are associated with 2 neurologic disorders, familial hemiplegic migraine and episodic ataxia 2. This gene also exhibits polymorphic variation due to (CAG)n-repeats. Multiple transcript variants encoding different isoforms have been found for this gene. In one set of transcript variants, the (CAG)n-repeats occur in the 3' UTR, and are not associated with any disease. But in another set of variants, an insertion extends the coding region to include the (CAG)n-repeats which encode a polyglutamine tract. Expansion of the (CAG)n-repeats from the normal 4-18 to 21-33 in the coding region is associated with spinocerebellar ataxia 6. [provided by RefSeq, Jul 2016]
CACNA1A Gene-Disease associations (from GenCC):
  • episodic ataxia type 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Illumina
  • developmental and epileptic encephalopathy, 42
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • migraine, familial hemiplegic, 1
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • spinocerebellar ataxia type 6
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet
  • benign paroxysmal torticollis of infancy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial or sporadic hemiplegic migraine
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Lennox-Gastaut syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0017878115).
BP6
Variant 19-13298658-T-A is Benign according to our data. Variant chr19-13298658-T-A is described in ClinVar as Benign. ClinVar VariationId is 68427.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.148 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001127222.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1A
NM_001127222.2
MANE Select
c.2975A>Tp.Glu992Val
missense
Exon 19 of 47NP_001120694.1
CACNA1A
NM_001127221.2
MANE Plus Clinical
c.2978A>Tp.Glu993Val
missense
Exon 19 of 47NP_001120693.1
CACNA1A
NM_023035.3
c.2987A>Tp.Glu996Val
missense
Exon 19 of 48NP_075461.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1A
ENST00000360228.11
TSL:1 MANE Select
c.2975A>Tp.Glu992Val
missense
Exon 19 of 47ENSP00000353362.5
CACNA1A
ENST00000638009.2
TSL:1 MANE Plus Clinical
c.2978A>Tp.Glu993Val
missense
Exon 19 of 47ENSP00000489913.1
CACNA1A
ENST00000638029.1
TSL:5
c.2987A>Tp.Glu996Val
missense
Exon 19 of 48ENSP00000489829.1

Frequencies

GnomAD3 genomes
AF:
0.134
AC:
20277
AN:
151782
Hom.:
1410
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.105
Gnomad AMI
AF:
0.163
Gnomad AMR
AF:
0.141
Gnomad ASJ
AF:
0.161
Gnomad EAS
AF:
0.123
Gnomad SAS
AF:
0.120
Gnomad FIN
AF:
0.123
Gnomad MID
AF:
0.182
Gnomad NFE
AF:
0.151
Gnomad OTH
AF:
0.149
GnomAD2 exomes
AF:
0.137
AC:
14100
AN:
102910
AF XY:
0.134
show subpopulations
Gnomad AFR exome
AF:
0.112
Gnomad AMR exome
AF:
0.146
Gnomad ASJ exome
AF:
0.164
Gnomad EAS exome
AF:
0.0934
Gnomad FIN exome
AF:
0.121
Gnomad NFE exome
AF:
0.148
Gnomad OTH exome
AF:
0.177
GnomAD4 exome
AF:
0.144
AC:
194404
AN:
1350598
Hom.:
14492
Cov.:
32
AF XY:
0.144
AC XY:
95757
AN XY:
666138
show subpopulations
African (AFR)
AF:
0.0978
AC:
2641
AN:
27012
American (AMR)
AF:
0.147
AC:
4253
AN:
28944
Ashkenazi Jewish (ASJ)
AF:
0.163
AC:
3820
AN:
23430
East Asian (EAS)
AF:
0.153
AC:
4545
AN:
29706
South Asian (SAS)
AF:
0.116
AC:
8669
AN:
74636
European-Finnish (FIN)
AF:
0.121
AC:
5745
AN:
47320
Middle Eastern (MID)
AF:
0.202
AC:
1109
AN:
5500
European-Non Finnish (NFE)
AF:
0.147
AC:
155295
AN:
1058490
Other (OTH)
AF:
0.150
AC:
8327
AN:
55560
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
9547
19095
28642
38190
47737
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5704
11408
17112
22816
28520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.133
AC:
20272
AN:
151890
Hom.:
1408
Cov.:
32
AF XY:
0.132
AC XY:
9802
AN XY:
74268
show subpopulations
African (AFR)
AF:
0.104
AC:
4330
AN:
41470
American (AMR)
AF:
0.141
AC:
2145
AN:
15258
Ashkenazi Jewish (ASJ)
AF:
0.161
AC:
558
AN:
3466
East Asian (EAS)
AF:
0.123
AC:
629
AN:
5130
South Asian (SAS)
AF:
0.120
AC:
578
AN:
4830
European-Finnish (FIN)
AF:
0.123
AC:
1293
AN:
10518
Middle Eastern (MID)
AF:
0.182
AC:
53
AN:
292
European-Non Finnish (NFE)
AF:
0.151
AC:
10226
AN:
67908
Other (OTH)
AF:
0.148
AC:
312
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
937
1873
2810
3746
4683
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
232
464
696
928
1160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.145
Hom.:
532
Bravo
AF:
0.135
TwinsUK
AF:
0.138
AC:
512
ALSPAC
AF:
0.146
AC:
563
ESP6500AA
AF:
0.0930
AC:
230
ESP6500EA
AF:
0.128
AC:
655
ExAC
AF:
0.112
AC:
2507
Asia WGS
AF:
0.113
AC:
392
AN:
3466

ClinVar

ClinVar submissions as Germline

Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
10
not specified (10)
-
-
1
Episodic ataxia type 2;C4310716:Developmental and epileptic encephalopathy, 42 (1)
-
-
1
Inborn genetic diseases (1)
-
-
1
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.23
BayesDel_addAF
Benign
-0.38
T
BayesDel_noAF
Benign
-0.18
CADD
Benign
22
DANN
Benign
0.91
DEOGEN2
Benign
0.031
T
Eigen
Benign
-0.31
Eigen_PC
Benign
-0.29
FATHMM_MKL
Benign
0.43
N
LIST_S2
Benign
0.69
T
MetaRNN
Benign
0.0018
T
MetaSVM
Benign
-0.61
T
MutationAssessor
Benign
1.1
L
PhyloP100
2.8
PrimateAI
Pathogenic
0.87
D
PROVEAN
Benign
-1.7
N
REVEL
Benign
0.28
Sift
Uncertain
0.029
D
Sift4G
Benign
0.16
T
Vest4
0.094
MPC
2.0
ClinPred
0.016
T
GERP RS
3.9
Varity_R
0.17
gMVP
0.52
Mutation Taster
=91/9
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs16023; hg19: chr19-13409472; COSMIC: COSV64201171; API